rs80356978
|
|
Neoplastic Syndromes, Hereditary
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.
|
26010302 |
2016 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
BRCA1 germline mutation and glioblastoma development: report of cases.
|
25880076 |
2015 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
|
25452441 |
2015 |
rs80356978
|
|
Neoplastic Syndromes, Hereditary
|
A |
0.700 |
CausalMutation
|
CLINVAR |
BRCA1 germline mutation and glioblastoma development: report of cases.
|
25880076 |
2015 |
rs80356978
|
|
Neoplastic Syndromes, Hereditary
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
|
22009639 |
2012 |
rs80356978
|
|
Neoplastic Syndromes, Hereditary
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
|
20104584 |
2010 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection.
|
19949876 |
2010 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.
|
19016756 |
2008 |
rs80356978
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
A |
0.700 |
CausalMutation
|
CLINVAR |
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
|
16683254 |
2006 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
MYC is amplified in BRCA1-associated breast cancers.
|
14760071 |
2004 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
|
11597388 |
2001 |
rs80356978
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
A |
0.700 |
CausalMutation
|
CLINVAR |
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
|
8554067 |
1996 |
rs80356978
|
|
Neoplastic Syndromes, Hereditary
|
A |
0.700 |
CausalMutation
|
CLINVAR |
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
|
8554067 |
1996 |
rs80356978
|
|
PANCREATIC CANCER, SUSCEPTIBILITY TO, 4
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs80356978
|
|
Malignant neoplasm of breast
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs80356978
|
|
FANCONI ANEMIA, COMPLEMENTATION GROUP S
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs80356978
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|